CAS 2379776-40-4

Plozasiran

Sinónimos:

• Plozasiran

Plozasiran

CAS: 2379776-40-4

Plozasiran, previously called ARO-APOC3, is a first-in-class investigational RNA interference (RNAi) therapeutic that is specifically designed to actively suppress hepatic production of apolipoprotein C-III (APOC3), a critical structural and functional component of triglyceride-rich lipoproteins (TRLs) and a central regulator of systemic triglyceride metabolism, thereby addressing dyslipidemia at the level of gene expression through targeted post-transcriptional silencing mechanisms.

Cor e Forma: White Solid

Peso molecular: 15618.77

Ref: TM-T210549